A small cap firm that’s primarily concerned in manufacturing and sale of Indian Made Overseas Liquor, is within the highlight after the inventory has delivered multi-bagger returns of p.c to the shareholders in 5 years.
With a market capitalization of Rs. 9,066.61 crore, the shares of Tilaknagar Industries Ltd closed at Rs. 467.80 per fairness share, down by 0.75 p.c from its earlier day’s shut worth of Rs. 471.35.
What’s the Information?
Over the previous 12 months, the inventory has supplied optimistic returns of greater than 46.90 p.c. The inventory is at present buying and selling at a reduction of 13.27 p.c from its 52-week excessive of Rs. 529.90.
On September 9, 2025, the shares of Tilaknagar Industries Ltd traded at Rs. 467.80, exhibiting a achieve of round 2,823.75 p.c in comparison with the value of Rs. 16 on October 1, 2020. For instance, if somebody had invested Rs. 1 lakh within the firm’s inventory 5 years in the past, it could have became round Rs. 29.24 lakh.
In regards to the Firm
Tilaknagar Industries Ltd is an Indian alcoholic beverage maker specializing in Indian Made Overseas Liquor (IMFL). Backed by a 90-year legacy and greater than 50 years of producing experience, the corporate manages a portfolio of over 15 manufacturers, produced by 4 owned services and 17 contract models throughout 10 states. In FY25, it bought 11.9 million circumstances, with brandy contributing 91 p.c of volumes and South India driving 86 p.c of gross sales.
Tilaknagar Industries Ltd follows an asset-light mannequin, with about 70 p.c of its manufacturing dealt with by contract manufacturing models. Its footprint spans 21 manufacturing models throughout 10 states, comprising 4 owned services and 17 contract models, whereas managing a portfolio of 15+ manufacturers throughout classes.
The corporate has 2 millionaire manufacturers of their portfolio, one is Mansion home, India’s largest and world’s second largest promoting manufacturers and the opposite is Courrier Napoleon which is third quickest rising model globally.
Different Updates
In July 2025, Tilaknagar Industries and its subsidiary Grain & Grape Works Pvt. Ltd. agreed to accumulate Pernod Ricard India’s Imperial Blue enterprise for about €413 million (Rs. 4,150 crore), with an extra €28 million (Rs. 282 crore) payable after 4 years. The deal covers model rights, two owned models, and co-manufacturing preparations, following IB’s FY25 gross sales of twenty-two.4 million circumstances. The acquisition, to be funded by debt and fairness, is anticipated to shut inside six months pending CCI approval.
Capital Expenditure Plans
Tilaknagar Industries, which is at present working at its full capability of 6 lakh circumstances yearly, has permitted an growth plan to extend capability to 36 lakh circumstances per 12 months inside the subsequent 12 months. The challenge, aimed toward assembly rising demand in Andhra Pradesh and making certain uninterrupted unique gross sales below its manufacturers, will contain a complete funding of Rs. 59 crore, together with round Rs. 34 crore in the direction of license charges and curiosity.
Monetary Highlights
In Q1FY26, the corporate reported income of Rs. 409 crore, up 30.7 p.c YoY from Rs. 313 crore and marginally larger by 0.7 p.c QoQ from Rs. 406 crore. Working revenue rose to Rs. 94 crore, exhibiting an 88 p.c YoY improve from Rs. 50 crore and a 20.5 p.c QoQ rise from Rs. 78 crore, reflecting improved operational effectivity.
Internet revenue stood at Rs. 89 crore in Q1FY26, elevated by 122.50 p.c YoY from Rs. 40 crore and rose 15.6 p.c QoQ from Rs. 77 crore. EPS improved to Rs. 4.57 towards Rs. 2.08 in Q1FY25 and Rs. 3.99 in Q4FY25, indicating sustained profitability development each yearly and sequentially.
Tilaknagar Industries Restricted’s income and internet revenue have grown at a CAGR of 17 p.c and 26 p.c, respectively, over the past 5 years. The corporate’s ROCE and ROE stand at 28.4 p.c and 29.9 p.c, respectively, and its debt-to-equity ratio at 0.05x signifies the corporate’s monetary place.
Written By Akshay Sanghavi
Disclaimer
The views and funding ideas expressed by funding specialists/broking homes/score companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of economic losses. Traders should subsequently train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Non-public Restricted or the writer aren’t accountable for any losses brought about because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
